Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Towa Ramps Up Profit Expectations As It Enjoys Sustained Domestic Demand
Japanese Firm Also Forecasts Lower Than Anticipated Full-Year R&D Spend
Nov 18 2024
•
By
Dave Wallace
Towa has revised up its profit expectations for this year
(Shutterstock)
More from Earnings
More from Generics Bulletin